Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
group_1_presentation_2_-alzheimer_s_disease [2017/11/04 00:55] tariqm2 [References] |
group_1_presentation_2_-alzheimer_s_disease [2018/01/25 15:18] (current) |
||
|---|---|---|---|
| Line 162: | Line 162: | ||
| Delacourte, A., & Defossez, A. (1986). Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. Journal of the neurological sciences, 76(2), 173-186. | Delacourte, A., & Defossez, A. (1986). Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. Journal of the neurological sciences, 76(2), 173-186. | ||
| + | |||
| + | DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J.-C., Paul, S. M., & Holtzman, D. M. (2001). Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America, 98(15), 8850–8855. http://doi.org/10.1073/pnas.151261398 | ||
| Ellis, J. M. (2005). Cholinesterase inhibitors in the treatment of dementia. The Journal of the American Osteopathic Association, 105(3), 145–158. https://doi.org/10.7556/JAOA.2005.105.3.145 | Ellis, J. M. (2005). Cholinesterase inhibitors in the treatment of dementia. The Journal of the American Osteopathic Association, 105(3), 145–158. https://doi.org/10.7556/JAOA.2005.105.3.145 | ||
